Arbutus, Burford Capital, and Cadiz with Chris DeMuth Jr.

Chris DeMuth Jr., an insightful analyst and author from Sifting the World, discusses the intriguing investment potential in biotech and litigation funding. He highlights the promising outlook for Arbutus Biopharma, emphasizing the stock's potential boost from ongoing legal battles. DeMuth also shares why Burford Capital is more than just a litigation powerhouse. Additionally, he presents Cadiz as his top investment pick, addressing the pressing need for innovative water management solutions in California's challenging infrastructure landscape.